Published in

Elsevier, Bioorganic and Medicinal Chemistry, 18(22), p. 5078-5090, 2014

DOI: 10.1016/j.bmc.2014.05.048

Links

Tools

Export citation

Search in Google Scholar

Taxanes with high potency inducing tubulin assembly overcome tumoural cell resistances

This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

We have found that four taxanes with chemical modifications at positions C10 and C13 were active against all types of taxane resistant cell lines, resistant by p-Gp overexpression, by mutations in the β-tubulin binding site or by overexpression of the highly dynamic βIII-tubulin isotype. We have characterized the interaction of taxanes with high activity on chemotherapy resistant tumoural cells with microtubules, and also studied their cellular effects. The biochemical property enhanced in comparison with other taxanes is their potency at inducing tubulin assembly, despite the fact that their interactions with the microtubule binding sites (pore and luminal) are similar as studied by NMR and SAXS. A differential interaction with the S7-S9 loop (M-loop) is responsible for their enhanced assembly induction properties. The chemical changes in the structure also induce changes in the thermodynamic properties of the interaction, indicating a higher hydrophilicity and also explaining their properties on p-Gp and βIII overexpressing cells and on mutant cells. The effect of the compounds on the microtubular network is different from those observed with the classical (docetaxel and paclitaxel) taxanes, inducing different bundling in cells with microtubules being very short, indicating a very fast nucleation effect and reflecting their high assembly induction power. ; 49 p.-7 tab.- 7 fig. ; This research was supported by BIPPED2 (S2010/BMD‐2457) (JFD), and MHit (CAM S2010/BMD-2353 to JJB) projects of the Comunidad de Madrid, the BIO2010‐16351 (to JFD) and CTQ2012-32025 (to JJB) projects from the Ministry of Economy and Competitiveness of Spain, a NSFC grant (No. 30930108) to (WF), the NIH/NCI CA103314 project (to IO) and a Ramon y Cajal grant to Dr. A. Canales.